Amycolatopsis mediterranei (Margalith and Beretta) Lechevalier et al.
商品貨號(hào)
B161870
Deposited As
Nocardia mediterranei(Margalith and Beretta) Thiemann et al.
Strain Designations
MM18-6
Application
Produces rifamycin P
Produces rifamycin Q
Produces rifamycin R
Produces rifamycin U
Isolation
Mutant derived from ATCC 13685
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Martinelli E, et al. Rifamycin R, a novel metabolite from a mutant of Nocardia mediterranea. J. Antibiot. 31: 949-951, 1978. PubMed: 711618
Lancini G, et al. Rifamycins P, Q, and U. US Patent 4,042,683 dated Aug 16 1977
Lechevalier MP, et al. Two new genera of nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.. Int. J. Syst. Bacteriol. 36: 29-37, 1986.
